Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Suspended × Capecitabine × Clear all

Phase

Phase 2 4 Phase 3 1

Status

Completed 116 Unknown 60 Recruiting 49 Active not recruiting 44 Terminated 25 Not yet recruiting 25 Withdrawn 5 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Radiation Injuries 1 Colorectal Neoplasms 1

Interventions

Paclitaxel 3 Doxorubicin 3 Cyclophosphamide 3 Vincristine 2 Rituximab 2 Radiotherapy 2 Oxaliplatin 2 Methotrexate 2 Fluorouracil 2 Cytarabine 2 titanium silicide 1 sargramostim 1 pegaspargase 1 exemestane 1 eribulin 1 durvalumab 1 ceralasertib 1 Thioguanine 1 Taxes 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Specimen Handling 1 S 1 (combination) 1 Prednisone 1 Prednisolone 1 Passive Cutaneous Anaphylaxis 1 Neoadjuvant Therapy 1 Morphine 1 Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02121405 2022-05-11

PSSR

Zhejiang University

Phase 3 Suspended

Gastrointestinal

Radiation Injuries, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡